Publications

Craig Byersdorfer

Braverman EL, Waltz G, Byersdorfer CA. Immunometabolism in haematopoietic stem cell transplantation and adoptive cellular therapies. Curr Opin Hematol. 2020 Nov;27(6):353-359. doi: 10.1097/MOH.0000000000000615. PubMed PMID: 33003083; PMCID: PMC8687629.
Beezhold K, Byersdorfer CA. Targeting immuno-metabolism to improve anti-cancer therapies. Cancer Lett. 2018 Feb 1;414127-135. doi: 10.1016/j.canlet.2017.11.005. PubMed PMID: 29126914; PMCID: PMC6447063.
Dolezal JM, Wang H, Kulkarni S, Jackson L, Lu J, Ranganathan S, Goetzman ES, Bharathi SS, Beezhold K, Byersdorfer CA, Prochownik EV. Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma. J Biol Chem. 2017 Jun 16;292(24):10068-10086. doi: 10.1074/jbc.M117.782052. PubMed PMID: 28432125; PMCID: PMC5473214.
Chiaranunt P, Ferrara JL, Byersdorfer CA. Rethinking the paradigm: How comparative studies on fatty acid oxidation inform our understanding of T cell metabolism. Mol Immunol. 2015 Dec;68(2 Pt C):564-74. doi: 10.1016/j.molimm.2015.07.023. PubMed PMID: 26359186.
Tkachev V, Goodell S, Opipari AW, Hao LY, Franchi L, Glick GD, Ferrara JL, Byersdorfer CA. Programmed death-1 controls T cell survival by regulating oxidative metabolism. J Immunol. 2015 Jun 15;194(12):5789-800. doi: 10.4049/jimmunol.1402180. PubMed PMID: 25972478; PMCID: PMC4562423.
Byersdorfer CA. The role of Fatty Acid oxidation in the metabolic reprograming of activated t-cells. Front Immunol. 2014;5641. doi: 10.3389/fimmu.2014.00641. PubMed PMID: 25566254; PMCID: PMC4270246.

<< Investigators Search

Top